17675-42-2

Basic information

• Product Name: 4-AMINO-N-CYCLOHEXYLBENZAMIDE
• Synonyms: 4-AMINO-N-CYCLOHEXYLBENZAMIDE;4-amino-N-cyclohexylbenzamide(SALTDATA: FREE)
• CAS NO: 17675-42-2
• Molecular Formula: C₁₃H₁₈N₂O
• Molecular Weight: 218.3
• Mol File: 17675-42-2.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 434.3°C at 760 mmHg
• Flash Point: 216.5°C
• Appearance: /
• Density: 1.11g/cm³
• Vapor Pressure: 9.58E-08mmHg at 25°C
• Refractive Index: 1.575
• CAS DataBase Reference: 4-AMINO-N-CYCLOHEXYLBENZAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-AMINO-N-CYCLOHEXYLBENZAMIDE(17675-42-2)
• EPA Substance Registry System: 4-AMINO-N-CYCLOHEXYLBENZAMIDE(17675-42-2)

Safety Data

• Hazardous Substances Data: 17675-42-2(Hazardous Substances Data)

Usage

General Description

4-AMINO-N-CYCLOHEXYLBENZAMIDE is a chemical compound with the molecular formula C13H17N3O and a molecular weight of 231.29 g/mol. It is a benzamide derivative with a cyclohexylamine moiety and an amino group. 4-AMINO-N-CYCLOHEXYLBENZAMIDE has been studied for its potential applications in pharmaceuticals and agrochemicals, as well as in the development of organic dyes and pigments. It is also used as a building block in chemical synthesis. 4-AMINO-N-CYCLOHEXYLBENZAMIDE may have potential biological activities and may be used as a precursor for the preparation of other organic compounds.

InChI:InChI=1/C13H18N2O/c14-11-8-6-10(7-9-11)13(16)15-12-4-2-1-3-5-12/h6-9,12H,1-5,14H2,(H,15,16)

Upstream product

• 7506-46-9 N-cyclohexyl-4-nitrobenzamide 
• 201230-82-2 carbon monoxide 
• 108-91-8 cyclohexylamine 
• 106-40-1 4-bromo-aniline 
• 150-13-0 4-amino-benzoic acid 
• 122-04-3 4-nitro-benzoyl chloride 
• 62-23-7 4-nitro-benzoic acid 
• 66493-39-8 4-(N-tert-butoxycarbonyl)aminobenzoic acid 

Downstream Products

• 947240-27-9 4-(2-bromoacetylamino)-N-cyclohexylbenzamide 
• 608523-54-2 6-[4-(Cyclohexylcarbamoyl)phenylazo]-pyridoxal-5-phosphate 

Relevant articles and documents

Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis

Sepsis, a systemic inflammatory response, caused by pathogenic factors including microorganisms, has high mortality and limited therapeutic approaches. Herein, a new soluble epoxide hydrolase (sEH) inhibitor series comprising a phenyl ring connected to a

sEH inhibitor and preparation method and application thereof

The invention provides an sEH inhibitor and a preparation method and application thereof, and relates to the technical field of endogenous active substance regulation and control. The sEH inhibitor provided by the invention has a structure as shown in a f

PURINE AND 3-DEAZAPURINE ANALOGUES AS CHOLINE KINASE INHIBITORS

There are provided substituted purine and 3-deazapurine analogues, which modulate the activity of Choline Kinase (ChoK). The compounds of this invention are therefore useful in treating diseases caused by an altered choline metabolism, such as cancer, cell proliferative disorders, infectious diseases of different origin, immune-related disorders and neurodegenerative disorders. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions comprising these compounds.